Erratum: Iron deficiency: An ominous sign in patients with systolicchronic heart failure (European Heart Journal (2010) 31 (1872-1880) DOI: 10.1093/eurheartj/ehq158);Iron deficiency: An ominous sign in patients with systolic chronic heart failure

European Heart Journal

Volumn 31, Issue 15, 2010, Pages 1872-1880

  Jankowska, Ewa A ^a,b   Rozentryt, Piotr ^c   Witkowska, Agnieszka ^b   Nowak, Jolanta ^c   Hartmann, Oliver ^d   Ponikowska, Beata ^a   Borodulin Nadzieja, Ludmila ^a   Banasiak, Waldemar ^b   Polonski, Lech ^c   Filippatos, Gerasimos ^e   McMurray, John J V ^f   Anker, Stefan D ^d,g   Ponikowski, Piotr ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Chronic heart failure; Iron deficiency; Survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; IRON DEFICIENCY; IRON INTAKE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SYSTOLIC HEART FAILURE;

EID: 77955453008     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr115     Document Type: Erratum

References (43)

1. Anderson GJ, Vulpe CD. Mammalian iron transport. Cell Mol Life Sci 2009;66: 3241-3261.
2. Cairo G, Bernuzzi F, Recalcati S. A precious metal: iron, an essential nutrient for all cells. Genes Nutr 2006;1:25-39.
3. Fairbanks V, Beutler E. Iron deficiency. In: Beutler E, ed., Williams Hematology. 6th ed. New York: McGraw-Hill; 2001. p295-304 and 447-450.
4. Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007;17:93-100.
5. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001;131(Suppl. 2):568S-579S.
6. Sutak R, Lesuisse E, Tachezy J, Richardson DR. Crusade for iron: iron uptake in unicellular eukaryotes and its significance for virulence. Trends Microbiol 2008; 16:261-268.
7. Wilson MT, Reeder BJ. Oxygen-binding haem proteins. Exp Physiol 2008;93: 128-132.
8. Rouault TA, Tong WH. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol 2005;6:345-351.
9. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370: 511-520.
10. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995.
11. Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroen-terol 2009;25:122-128.
12. Baker JF, Ghio AJ. Iron homoeostasis in rheumatic disease. Rheumatology 2009;48: 1339-1344.
13. Balla J, Jeney V, Varga Z, Komódi E, Nagy E, Balla G. Iron homeostasis in chronic inflammation. Acta Physiol Hung 2007;94:95-106.
14. Zafon C, Lecube A, Simó R. Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev 2010;11:322-328.
15. Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastro-enterol 2009;15:4659-4665.
16. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009;1790:682-693.
17. Gisbert JP, Gomollon F. An update on iron physiology. World J Gastroenterol 2009; 15:4617-4626.
18. Haas JD, Brownlie T 4th. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001;131: 676S-690S.
19. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, for the FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448.
20. Hinton PS, Sinclair LM. Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. Eur J Clin Nutr 2007;61:30-39.
21. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-2237.
22. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006;48:2485-2489.
23. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223-225.
24. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-1227.
25. Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665.
26. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103-112.
27. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenous iron without ery-thropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008; 21:236-242.
28. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Mori C, von Eisenhart Rothe B, Pocock S, Poole-Wilson PA, Ponikowski P, FAIR-HF Committees Investigators. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic heart failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 2009;11:1084-1091.
29. Blanc B, Finch CA, Hallberg L, Nutritional anaemias. Report of a WHO scientific group. WHO Tech Rep Ser 1968;405:1-40.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
31. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006;113:2454-2461.
32. Weiss G, Goodnough LT. Anemia of chronic disease. N Eng J Med 2005;352: 1011-1023.
33. Handelman GJ, Levin NW. Iron anemia in human biology: a review of mechanisms. Heart Fail Rev 2008;13:393-404.
34. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica 2008;93:90-97.
35. Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie 2009;91:1223-1228.
36. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, Piepoli MF, Anker SD, Banasiak W, Ponikowski P. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003;90: 303-308.
37. Silverberg DS, Wexler D, Iaina A, Schwartz D. The role of correction of anaemia in patients with congestive heart failure: a short review. Eur J Heart Fail 2008;10: 819-823.
38. Toblli JE, Cao G, Rivas C, Kulaksiz H. Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin. Nephrology 2008;13:636-645.
39. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 2007;148:2663-2668.
40. Isoda M, Hanawa H, Watanabe R, Yoshida T, Toba K, Yoshida K, Kojima M, Otaki K, Hao K, Ding L, Tanaka K, Takayama T, Kato K, Okura Y, Kodama M, Ota Y, Hayashi J, Aizawa Y. Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction. J Nutr Biochem 2009; doi:10.1016/j.jnutbio.2009.04.009. Published online ahead of print 15 July 2009.
41. Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cyto-chrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci 2005;109:277-286.
42. Turner LR, Premo DA, Gibbs BJ, Hearthway ML, Motsko M, Sappington A, Walker L, Mullendore ME, Chew HG Jr. Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy. BMC Physiol 2002;2:1.
43. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10:933-989.